4//SEC Filing
Robinson Chandler 4
Accession 0001437749-25-022861
CIK 0001645469other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 9:02 PM ET
Size
9.6 KB
Accession
0001437749-25-022861
Insider Transaction Report
Form 4
Robinson Chandler
DirectorChief Executive Officer
Transactions
- Exercise of In-Money
Common Stock
2025-07-14$0.01/sh+16,800$84→ 90,272 total - Sale
Common Stock
2025-07-14$40.00/sh−16,800$672,020→ 73,472 total - Exercise of In-Money
Stock Options
2025-07-14−16,800→ 0 totalExercise: $0.01Exp: 2027-02-20→ Common Stock (16,800 underlying)
Holdings
- 822,255(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]This transaction involved a cash exercise of stock options.
- [F2]The shares were sold in multiple transactions at prices ranging from $40.00 to $40.25, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]As a manager of Tactic Pharma LLC, Dr. Robinson may be deemed to share voting and dispositive power over these 822,255 shares. Dr. Robinson disclaims beneficial ownership of the 822,255 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
- [F4]Reflects options to purchase up to 16,800 shares of common stock granted to Dr. Robinson on February 20, 2017, for his services as a director and officer of Monopar Therapeutics. The options vested 6/48ths upon the 6-month anniversary of the grant date and 1/48th per month thereafter.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
Related Parties
1- filerCIK 0001727334
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 9:02 PM ET
- Size
- 9.6 KB